Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03119467
Title Safety and Efficacy Study of RP4010, in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Rhizen Pharmaceuticals SA
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
University of Alabama Birmingham Alabama 35294-3300 United States Details
City of Hope Duarte California 91010 United States Details
University of Colorado Aurora Colorado 80045 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201 United States Details
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 United States Details
Utah Cancer Specialists Salt Lake City Utah 84106 United States Details
St Vincent's Hospital Sidney New South Wales 2010 Australia Details
Pindara Private Hospital Benowa Queensland 4217 Australia Details
Brisbane Clinic for Lymphoma, Myeloma and Leukaemia Greenslopes Queensland 4120 Australia Details
Epworth HealthCare Richmond Victoria 3121 Australia Details
*Shaded cells indicate that there was no data available from for the field